<VariationArchive RecordType="classified" VariationID="2425135" VariationName="NC_000002.11:g.(?_231033840)_(231081642_?)del" VariationType="Deletion" Accession="VCV002425135" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1946199" VariationID="2425135">
      <GeneList>
        <Gene Symbol="SP110" FullName="SP110 nuclear body protein" GeneID="3431" HGNC_ID="HGNC:5401" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q37.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="230165186" stop="230225636" display_start="230165186" display_stop="230225636" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="231033633" stop="231090443" display_start="231033633" display_stop="231090443" Strand="-" />
          </Location>
          <OMIM>604457</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_231033840)_(231081642_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q37.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="231033840" innerStop="231081642" display_start="231033840" display_stop="231081642" variantLength="47803" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_231033840)_(231081642_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_231033840)_(231081642_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_231033840)_(231081642_?)del AND Hepatic veno-occlusive disease-immunodeficiency syndrome" Accession="RCV003113502" Version="3">
        <ClassifiedConditionList TraitSetID="1553">
          <ClassifiedCondition DB="MedGen" ID="C1856128">Hepatic veno-occlusive disease-immunodeficiency syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16648851</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22621957</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1553" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2320" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hepatic venoocclusive disease with immunodeficiency</ElementValue>
                <XRef ID="Hepatic+venoocclusive+disease+with+immunodeficiency/3331" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic Veno-occlusive Disease with Immunodeficiency</ElementValue>
                <XRef ID="NBK1271" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hepatic veno-occlusive disease-immunodeficiency syndrome</ElementValue>
                <XRef ID="MONDO:0009338" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VODI</ElementValue>
                <XRef Type="MIM" ID="235550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000319395" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hepatic veno-occlusive disease with immunodeficiency (VODI) is characterized by: (1) primary immunodeficiency; and (2) terminal hepatic lobular vascular occlusion and hepatic fibrosis manifest as hepatomegaly and/or hepatic failure. Onset is usually before age six months. The immunodeficiency comprises severe hypogammaglobulinemia, clinical evidence of T-cell immunodeficiency with normal numbers of circulating T cells, absent lymph node germinal centers, and absent tissue plasma cells. Bacterial and opportunistic infections including Pneumocystis jirovecii infection, mucocutaneous candidiasis, and enteroviral or cytomegalovirus infections occur. In the past the prognosis for affected individuals was poor, with 100% mortality in the first year of life if unrecognized and untreated with intravenous immunoglobulin (IVIG) and Pneumocystis jirovecii prophylaxis. However, with early recognition and treatment there is a marked improvement in prognosis.</Attribute>
                <XRef ID="NBK1271" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10083" />
                <XRef ID="10083" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301448</ID>
                <ID Source="BookShelf">NBK1271</ID>
              </Citation>
              <XRef ID="79124" DB="Orphanet" />
              <XRef ID="C1856128" DB="MedGen" />
              <XRef ID="MONDO:0009338" DB="MONDO" />
              <XRef Type="MIM" ID="235550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7074005" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_004509.3_Deletion (Entire Coding Sequence)|MedGen:C1856128" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003793770" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16648851</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22621957</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the SP110 gene has been identified. Loss-of-function variants in SP110 are known to be pathogenic (PMID: 16648851, 22621957). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with SP110-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SP110" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_231033840)_(231081642_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856128" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7074005" TraitType="Disease" MappingType="XRef" MappingValue="C1856128" MappingRef="MedGen">
        <MedGen CUI="C1856128" Name="Hepatic veno-occlusive disease-immunodeficiency syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

